Bibliographie (2546)
COVID Morbidity – The emerging burden of long COVID is significant, and needs to be considered when evaluating the risk vs. benefit of pandemic measures.
jeudi, 27 mai 2021 11:02 Écrit par Zouhair SouissiCOVID Morbidity – Science-Based Medicine
The post COVID Morbidity – The emerging burden of long COVID is significant, and needs to be considered when evaluating the risk vs. benefit of pandemic measures. appeared first on Links Medicus.
Systematic review of 45 studies including 9751 participants, most of which were hospitalized, found 73% had at least 1 persistent symptom for weeks after Covid-19.
jeudi, 27 mai 2021 11:02 Écrit par Zouhair SouissiAssessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review – JAMA Network Open Commentary: Seven out of ten hospitalized COVID-19 patients will have long-haul symptoms – MedicalXpress
The post Systematic review of 45 studies including 9751 participants, most of which were hospitalized, found 73% had at least 1 persistent symptom for weeks after Covid-19. appeared first on Links Medicus.
Count the cost of disability caused by COVID-19 – “Focusing only on cases and deaths hides the pandemic’s lasting health burden on people, societies and economies”.
jeudi, 27 mai 2021 11:02 Écrit par Zouhair SouissiCount the cost of disability caused by COVID-19 – Nature
The post Count the cost of disability caused by COVID-19 – “Focusing only on cases and deaths hides the pandemic’s lasting health burden on people, societies and economies”. appeared first on Links Medicus.
RCT: 2 inactivated SARS-CoV-2 vaccines show efficacy of 72.8% and 78.1% on symptomatic COVID-19 infection in adults.
jeudi, 27 mai 2021 11:02 Écrit par Zouhair SouissiEffect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial – JAMA Commentary: China’s Sinopharm Publishes Awaited Covid Vaccine Study Details – Bloomberg Commentary on Twitter (thread – click for more) The #4Humanity phase 3 trial of Sinopharm's Beijing & Wuhan vaccines published in JAMA by @NawalAlKaabi &co […]
The post RCT: 2 inactivated SARS-CoV-2 vaccines show efficacy of 72.8% and 78.1% on symptomatic COVID-19 infection in adults. appeared first on Links Medicus.
![[Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance](/media/k2/items/cache/e7d681ddc0174087ad0e36dc718519dd_M.jpg)
[Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance
mercredi, 26 mai 2021 13:30 Écrit par Zouhair SouissiIvermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – medRxiv Commentary on Twitter ???PreprintIvermectin for the treatment of #COVID19 : A systematic review & meta-analysis of RCTs10 RCTs1173 patients 8 RCTs➡️ Mild1 RCT ➡️ Moderate1 RCT➡️ Mild& modIvermectin did not reduce all-cause mortality,length of stay or viral […]
The post [Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance appeared first on Links Medicus.
Estimating infectiousness throughout SARS-CoV-2 infection course – 8% of subjects had very high viral loads, one-third of whom had little to no symptoms; in individuals infected with the B.1.1.7 variant, average viral loads were 10 times higher.
mercredi, 26 mai 2021 13:30 Écrit par Zouhair SouissiEstimating infectiousness throughout SARS-CoV-2 infection course – Science Commentary: Estimating infectiousness of SARS-CoV-2: New study on viral load – Universitätsmedizin Berlin Commentary on Twitter Of 25,000+ people who tested positive for #COVID19 in Germany, 8% had very high viral loads; about a third of these had little to no symptoms. The results suggest asymptomatic […]
The post Estimating infectiousness throughout SARS-CoV-2 infection course – 8% of subjects had very high viral loads, one-third of whom had little to no symptoms; in individuals infected with the B.1.1.7 variant, average viral loads were 10 times higher. appeared first on Links Medicus.
COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence – “viral load was tenfold higher in P.1 infections than in non-P.1”.
mercredi, 26 mai 2021 13:30 Écrit par Zouhair SouissiCOVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence – Nature Medicine
The post COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence – “viral load was tenfold higher in P.1 infections than in non-P.1”. appeared first on Links Medicus.
What scientists know about new, fast-spreading coronavirus variants.
mercredi, 26 mai 2021 13:30 Écrit par Zouhair SouissiWhat scientists know about new, fast-spreading coronavirus variants – Nature
The post What scientists know about new, fast-spreading coronavirus variants. appeared first on Links Medicus.
Short review: Diagnosis and management of acute respiratory distress syndrome
mercredi, 26 mai 2021 10:21 Écrit par Zouhair SouissiDiagnosis and management of acute respiratory distress syndrome – Canadian Medical Association Journal Commentary on Twitter #ARDS is an important priority in our ICUs at the moment. Our @CMAJ review looks at diagnosis, and provides a guideline-based approach to management, along with a discussion on #COVID19 ARDS. A great primer for those new to […]
The post Short review: Diagnosis and management of acute respiratory distress syndrome appeared first on Links Medicus.
Perspective | Coronavirus: so many variants, but vaccines are still effective.
mardi, 25 mai 2021 11:08 Écrit par Zouhair SouissiCoronavirus: so many variants, but vaccines are still effective – The Conversation
The post Perspective | Coronavirus: so many variants, but vaccines are still effective. appeared first on Links Medicus.
